Posterior Column Spinal Osteotomies in the Treatment of Adolescent Idiopathic Scoliosis
Launched by TURKU UNIVERSITY HOSPITAL · May 17, 2022
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a surgical technique called posterior column osteotomies (PCO) to see if it helps improve the correction of spine curves in adolescents with idiopathic scoliosis, a condition where the spine bends abnormally. The researchers want to find out if using PCO during spinal fusion surgery leads to better results in correcting the spine's shape compared to not using this technique. The trial will involve 60 adolescents, aged 10 to 21, who are undergoing surgery for a significant spinal curve (Cobb angle of 45 degrees or more).
Participants in the trial will be randomly assigned to either the PCO group or a group that does not receive PCO, and all surgeries will be performed at multiple centers. Throughout the study, researchers will look at various outcomes, such as how well the spine's shape improves, any changes in quality of life, pain levels after surgery, and the length of hospital stays. Importantly, ethical approval for the study has been obtained, and all participants and their families will provide informed consent before joining. There are no extra costs for participants since the information gathered will be part of the standard care for scoliosis surgery.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adolescent idiopathic scoliosis (Lenke 1 to 4)
- • Age at surgery between 10 and 21 years
- • Cobb angle of 45 degrees or more
- • Posterior spinal fusion
- Exclusion Criteria:
- • Anteroposterior surgery
- • Vertebral column resection
- • Smoking
- • Diabetes mellitus
- • Bleeding disorder
About Turku University Hospital
Turku University Hospital (TYKS) is a leading academic medical center located in Turku, Finland, renowned for its commitment to advancing healthcare through innovative research and clinical excellence. As a key institution within the University of Turku, TYKS integrates cutting-edge medical education with state-of-the-art clinical services, offering a broad spectrum of specialized care. The hospital actively participates in clinical trials, facilitating the translation of scientific discoveries into practical treatments, and enhancing patient outcomes. With a multidisciplinary approach and a focus on collaboration, TYKS aims to contribute significantly to the global medical community through its rigorous research initiatives and commitment to patient-centered care.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Turku, , Finland
Helsinki, , Finland
Turku, , Finland
Patients applied
Trial Officials
Ilkka Helenius, MD, PhD
Study Director
Helsinki University Central Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials